MyAverix Finance
SA · Healthcare
Ascendis Pharma A/S (A1SN34)
Biotechnology
Ascendis Pharma A/S (A1SN34) is listed on SA in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $74.52B, P/E ratio is 18.00, net margin is -31.7%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for A1SN34
Ascendis Pharma A/S (A1SN34) — FAQ
What is Ascendis Pharma A/S's market cap?
Ascendis Pharma A/S (A1SN34) has a reported market cap of $74.52B (data as of 2026-03-29).
What is A1SN34's P/E ratio?
The price-to-earnings (P/E) ratio for Ascendis Pharma A/S (A1SN34) is 18.00 (data as of 2026-03-29).
Does Ascendis Pharma A/S pay a dividend?
Dividend yield is not available in the current snapshot for Ascendis Pharma A/S (A1SN34). Check the MyAverix Finance app for the latest dividend data.
What sector is Ascendis Pharma A/S in?
Ascendis Pharma A/S (A1SN34) is classified in the Healthcare sector (Biotechnology industry).
What exchange is A1SN34 listed on?
A1SN34 is listed on SA.
What is Ascendis Pharma A/S's net margin?
Ascendis Pharma A/S (A1SN34) reports a net margin of -31.7% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.